Portfolio company
Glass Medical AI
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops predictive AI technology for oncology drug development and patient stratification for pharmaceutical and biotech partners.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
StratifAI
This company develops multimodal artificial intelligence biomarkers to predict cancer recurrence risks from pathology slides for oncologists and pharmaceutical organisations.
Onc.AI
This company develops AI-powered software that analyses medical imaging to predict cancer patient outcomes for pharmaceutical firms and medical oncologists.
Orakl Oncology
This company develops a predictive platform using patient tumor avatars and data to help pharmaceutical firms accelerate and de-risk cancer drug development.
Known Medicine
This company develops a platform using 3D cell culture and artificial intelligence to predict drug responses for oncologists and biopharmaceutical developers.
Ataraxis AI
This company develops artificial intelligence models that predict cancer outcomes and treatment responses for healthcare providers and oncologists.
Gatchealth
This company develops an artificial intelligence platform for drug discovery and risk assessment for biopharmaceutical companies and investors.
Omica
This company develops artificial intelligence software to screen pathology slides for cancer biomarkers, serving hospital laboratories and biopharmaceutical partners to improve patient therapy selection.
AI Pathology
This company develops artificial intelligence software for cancer diagnosis and digital pathology image analysis to support pathologists and laboratories.